Tymlos
Chemical Name | abaloparatide |
Dosage Form | Injection (subcutaneous; 3120 mcg/1.56 mL) |
Drug Class | Analogs |
System | Musculoskeletal |
Company | Radius Health |
Approval Year | 2017 |
Indication
- For the treatment of postmenopausal women with osteoporosis at high risk for fracture